InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Sitar Edward J, Chief Financial Officer. Officer active across 2 companies, notably 9 METERS BIOPHARMA, INC.. Cumulatively, 5 reports have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €43k. History available since 14 September 2021. The latest transaction was disclosed on 15 April 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
150,000 shares0Common Stock, par value $0.001 per shareSEC:0001104659-22-047216:0
15,000 shares@ US$0.4650.0% of flowCommon Stock, par value $0.001 per shareSEC:0000905718-21-001533:0
Ideal exit: 20 Aug 2022 (T+270)
15,000 shares@ US$0.46100.0% of flowCommon Stock, par value $0.001 per shareSEC:0000905718-21-001533
Ideal exit: 20 Aug 2022 (T+270)
15,000 shares@ US$1.22100.0% of flowCommon stockSEC:0001551986-21-000103
Ideal exit: 11 Jun 2022 (T+270)
15,000 shares@ US$1.2250.0% of flowCommon stockSEC:0001551986-21-000103:0
Ideal exit: 11 Jun 2022 (T+270)
5 of 5 declarations
About Sitar Edward J
Edward J. Sitar is the Chief Financial Officer and Board Member at 9 Meters Biopharma, Inc. and Timber Pharmaceuticals, Inc. He is responsible for financial management and the financial strategy of these companies. His role includes overseeing accounting operations and managing financial risks. Through his expertise, he contributes to informed decision-making and the sustainable growth of the companies.
